Shuai Jiang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Epidermal Growth Factor Receptor

Positive Breast Cancer

Systematic Review

Ejection Fraction

Top Venues

Immunopharmacology and immunotoxicology

Cancer chemotherapy and pharmacology

Journal of biomaterials applications

This page only lists publications with an associated author ORCID identifier.

Publications

Shuai Geng, Tong Liu, Nan Wang, Xinyue Gao, Xinyu Luo, Ning Shi, Shuai Jiang
Systematic review of the efficacy and safety of lenvatinib in various solid tumors. Immunopharmacology and immunotoxicology (2024)
Shuai Geng, Tong Liu, Nan Wang, Xinyue Gao, Xinyu Luo, Ning Shi, Shuai Jiang
Systematic review of the efficacy and safety of lenvatinib in various solid tumors. Immunopharmacology and immunotoxicology 46 (3) (2024)
Shuai Geng, Tong Liu, Nan Wang, Xinyue Gao, Xinyu Luo, Ning Shi, Shuai Jiang
Systematic Review of the Efficacy and Safety of Lenvatinib in Various Solid Tumors. Immunopharmacology and immunotoxicology (2024)
Shuai Geng, Tong Liu, Nan Wang, Xinyue Gao, Xinyu Luo, Ning Shi, Shuai Jiang
Systematic review of the efficacy and safety of lenvatinib in various solid tumors. Immunopharmacology and immunotoxicology 46 (3) (2024)
Mengfei Cheng, Fang Yang, Yanchao Yang, Xinyue Gao, Yang Yu, Nan Wang, Xinyu Luo, Shuo Zhang, Shuai Jiang, Mei Dong
Correlation analysis between camrelizumab trough concentration levels and efficacy or safety in East Asian patients with advanced lung cancer. Cancer chemotherapy and pharmacology (2023)
Shuai Jiang, Shuai Geng, Xinyue Gao, Tong Liu, Xinyu Luo, Nan Wang, Ning Shi, Mei Dong
Evaluation of HER-2 positive breast cancer treated with dual-targeted treatment of Trastuzumab plus Pertuzumab. Immunopharmacology and immunotoxicology (2023)
Shuai Jiang, Shuai Geng, Xinyue Gao, Tong Liu, Xinyu Luo, Nan Wang, Ning Shi, Mei Dong
Evaluation of HER-2 positive breast cancer treated with dual-targeted treatment of trastuzumab plus pertuzumab. Immunopharmacology and immunotoxicology (2023)
Zhiqiang Tong, Mengfei Cheng, Yang Yu, Jiuhang Yu, Yichuang Yin, Jiahui Liu, Shuo Zhang, Shuai Jiang, Mei Dong
Correlation between pharmacokinetic parameters of 5-fluorouracil and related metabolites and adverse reactions in East-Asian patients with advanced colorectal cancer. Cancer chemotherapy and pharmacology 89 (3) (2022)
Jiuhang Yu, Yichuang Yin, Yang Yu, Mengfei Cheng, Shuo Zhang, Shuai Jiang, Mei Dong
Effect of concomitant antibiotics use on patient outcomes and adverse effects in patients treated with ICIs. Immunopharmacology and immunotoxicology (2022)
Shuai Jiang, Miao Yu, Haoyang Wang, Songqi Han, Mengfei Cheng, Shuo Zhang, Jiahui Liu, Xinghua Wang, Mei Dong
131I-radioisotope modified in PEGylation metal organic frameworks for sensitization in refractory differentiated thyroid cancer treatment. Journal of biomaterials applications 36 (5) (2021)